乙肝病毒核心抗原单链抗体细胞内免疫抗乙肝病毒基因治疗研究
陆荫英,王琳,刘妍,李克,王业东,张玲霞,成军,于敏,项目负责人,InhibitoryeffectofHBcAgScFvonhepatitisBvirus,Supportedby,Correstpondenceto:,Received,Accepted,Abstract,摘要,方法,:,结果,结论,0,引言,1材料
陆荫英,王琳,刘妍,李克,王业东,张玲霞,成军,中国人民解放军第302医院传染病研究所基因治疗研究中心,全军病毒性肝炎防治研究重点实验室 北京市 100039于敏,北京大学第一医院感染病科 北京市 100034
国家自然科学基金攻关项目, No.C03011402,军队“十、五”科技攻关面上项目, No.01MB135
项目负责人 成军,中国人民解放军第302医院传染病研究所基因治疗研究中心,北京市 100039. cj@genetherapy.com.cn
电话:010-66933392 传真:010-63801283
收稿日期 2002-03-29 接受日期 2002-05-21
Inhibitory effect of HBcAg ScFv on hepatitis B virus
Yin-Ying Lu,Lin Wang,Yan Liu,Min Yu,Ke Li,Ye-Dong Wang, Ling-Xia Zhang, Jun Cheng Yin-Ying Lu,Lin Wang,Yan Liu,Ke Li, Ye-Dong Wang, Ling-Xia Zhang, Jun Cheng, Gene Therapy Research Center, Institute of Infectious Diseases, The 302 Hospital of PLA, Beijing 100039, China
Min Yu,Department of Infectious Diseases, The First Hospital of Beijing Unversity, beijing, 100034.
Supported by the Natural Science Foundation of China, No . C03011402.
Correstpondence to: Jun Cheng, Gene Therapy Research Center, Institute of Infectious Diseases, The 302 Hospital of PLA, Beijing 100039, China. cj@genetherapy.com.cn
Received 2002-03-29 Accepted 2002-05-21 ......
您现在查看是摘要页,全文长 17908 字符。